Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shunnan Yao
Institutions:
First Affiliated Hospital Zhejiang University,
Zhejiang University
Observed institutions:
Ningbo University,
First Affiliated Hospital Zhejiang University,
Zhejiang University
OpenAlex ID:
A5089087795
DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo
2020
·
Shunnan Yao
, Jianpin Ye
, et al.
·
Cancer Letters
·
53
Camalexin Induces Apoptosis via the ROS‐ER Stress‐Mitochondrial Apoptosis Pathway in AML Cells
2018
·
Yang Yang
, Gang Wang
, et al.
·
Oxidative Medicine and Cellular Longevity
·
43
NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma
2022
·
Xi Huang
, Wen Cao
, et al.
·
Cell Death and Disease
·
27
PDF
Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells
2018
·
Yi Zhao
, Enfan Zhang
, et al.
·
Cellular Physiology and Biochemistry
·
23
TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting prosurvival autophagy
2023
·
Jing Chen
, Wen Cao
, et al.
·
Blood Advances
·
21
PDF
CUDC-101 as a dual-target inhibitor of EGFR and HDAC enhances the anti-myeloma effects of bortezomib by regulating G2/M cell cycle arrest
2023
·
Wen Cao
, Shunnan Yao
, et al.
·
Journal of Zhejiang University SCIENCE B
·
8
PDF
High-Order Fiber Mode Beam Parameter Optimization for Transport and Rotation of Single Cells
2021
·
Zihao Shan
, Shunnan Yao
, et al.
·
Micromachines
·
2
PDF
NAMPT in macrophages promotes multiple myeloma drug resistance through mitochondrial metabolic reprogramming and modulates immunosuppression via the SIRT1/STAT3/SPP1 axis.
2025
·
Shunnan Yao
, Gang Xiao
, et al.
·
Blood
·
1
PDF
A positive feedback loop between YTHDC1 and EP300 drives multiple myeloma tumorigenesis
2026
·
Yifan Hou
, Qiqi Shen
, et al.
·
Oncogene
The m5C-binding protein YB-1 modulates proteasome inhibitors resistance in multiple myeloma via epigenetic modification
2025
·
Qiqi Shen
, Xi Huang
, et al.
·
Blood
PDF
Targeting CCR7 ubiquitination to disrupt protumoral macrophages: A NEDD4-1-dependent strategy to reverse bortezomib resistance in myeloma
2025
·
Xi Huang
, Shunnan Yao
, et al.
·
Blood
Deciphering the cellular hierarchy of multiple myeloma uncovers a therapeutically exploitable EP300/TBX2 axis in LILRB4+ myeloma-initiating cells
2025
·
Haoguang Chen
, Shanshan Pei
, et al.
·
Blood
PDF
NAMPT in Myeloma-Associated Macrophages Drives Drug Resistance through Mitochondrial Metabolic Reprogramming and Immune Evasion via the SIRT1/STAT3/SPP1 Axis
2025
·
Shunnan Yao
, Xi Huang
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
NEDD4-1-Mediated Ubiquitination of CCR7 Reprograms Macrophage Function and Enhances theraputic Sensitivity in Multiple Myeloma
2025
·
Xi Huang
, Shunnan Yao
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
Show more works
View as search
Works count:
14
Citation count:
178
H-index:
6
I10-index:
5
Year
Topic
Type